Index - P/E 23.95 EPS (ttm) 13.10 Insider Own 18.87% Shs Outstand 29.77M Perf Week 1.69%
Market Cap 9.02B Forward P/E 23.82 EPS next Y 13.18 Insider Trans -0.11% Shs Float 23.32M Perf Month 5.66%
Enterprise Value 8.73B PEG 4.78 EPS next Q 2.98 Inst Own 90.81% Short Float 13.27% Perf Quarter 0.48%
Income 416.39M P/S 4.18 EPS this Y 1.02% Inst Trans 0.35% Short Ratio 6.11 Perf Half Y -8.41%
Sales 2.16B P/B 15.74 EPS next Y 3.29% ROA 22.55% Short Interest 3.09M Perf YTD -5.53%
Book/sh 19.94 P/C 20.44 EPS next 5Y 5.01% ROE 65.82% 52W High 459.77 -31.74% Perf Year -22.57%
Cash/sh 15.36 P/FCF 16.68 EPS past 3/5Y 37.94% 36.50% ROIC 57.81% 52W Low 250.05 25.52% Perf 3Y 107.40%
Dividend Est. - EV/EBITDA 17.98 Sales past 3/5Y 22.68% 19.62% Gross Margin 30.16% Volatility 2.39% 2.93% Perf 5Y 246.96%
Dividend TTM - EV/Sales 4.05 EPS Y/Y TTM 32.81% Oper. Margin 21.16% ATR (14) 8.98 Perf 10Y -
Dividend Ex-Date - Quick Ratio 0.73 Sales Y/Y TTM 9.87% Profit Margin 19.31% RSI (14) 57.22 Recom 2.77
Dividend Gr. 3/5Y - - Current Ratio 0.73 EPS Q/Q 14.63% SMA20 3.03% Beta 1.47 Target Price 300.90
Payout 0.00% Debt/Eq 0.25 Sales Q/Q 9.30% SMA50 4.22% Rel Volume 0.41 Prev Close 310.69
Employees 5900 LT Debt/Eq 0.21 Earnings Jul 21 AMC SMA200 -3.97% Avg Volume 506.86K Price 313.86
IPO Aug 11, 2016 Option/Short Yes / Yes EPS/Sales Surpr. 19.95% 6.12% Trades
Volume 206,775 Change 1.02%
Date
Action
Analyst
Rating Change
Price Target Change
Jun-24-25 Initiated Barclays
Equal Weight
$300
Apr-22-25 Downgrade William Blair
Outperform → Mkt Perform
Apr-14-25 Downgrade TD Cowen
Buy → Hold
$328
Mar-24-25 Initiated Leerink Partners
Market Perform
$330
Oct-23-24 Downgrade Robert W. Baird
Outperform → Neutral
$413 → $349
Oct-14-24 Initiated Redburn Atlantic
Buy
Sep-27-24 Downgrade UBS
Buy → Neutral
$420 → $350
Sep-25-24 Downgrade Jefferies
Buy → Hold
$415 → $345
Aug-01-24 Initiated Truist
Hold
$415
May-29-24 Initiated TD Cowen
Buy
$452
May-28-24 Initiated Mizuho
Buy
$435
Apr-23-24 Upgrade Jefferies
Hold → Buy
$340 → $450
Mar-18-24 Initiated Deutsche Bank
Hold
$395
Feb-15-24 Upgrade UBS
Neutral → Buy
$282 → $452
Oct-24-23 Upgrade Robert W. Baird
Neutral → Outperform
$270 → $289
May-08-23 Upgrade Guggenheim
Neutral → Buy
$252
Oct-27-22 Upgrade UBS
Sell → Neutral
$142 → $238
Sep-07-22 Initiated UBS
Sell
$142
May-24-22 Initiated Guggenheim
Neutral
Aug-05-21 Resumed Credit Suisse
Outperform
$205
Show Previous Ratings
Jun-26-25 06:15PM
Jun-24-25 11:31PM
Jun-23-25 04:05PM
Jun-18-25 12:05AM
Jun-17-25 06:15PM
08:07AM
Loading…
08:07AM
Jun-10-25 06:15PM
Jun-09-25 11:40AM
May-27-25 07:00PM
May-21-25 11:27AM
May-14-25 11:40AM
May-13-25 06:20AM
Apr-30-25 04:33AM
Apr-28-25 08:46PM
11:59AM
11:40AM
Loading…
11:40AM
03:08AM
Apr-25-25 12:09PM
Apr-24-25 10:08AM
07:35AM
Apr-23-25 03:04AM
12:15AM
(Thomson Reuters StreetEvents)
Apr-22-25 04:03PM
(Investor's Business Daily)
03:42PM
03:21PM
02:32PM
Apr-21-25 05:25PM
04:24PM
04:21PM
(Associated Press Finance)
04:15PM
08:00AM
Loading…
Apr-20-25 08:00AM
Apr-18-25 08:31AM
Apr-15-25 10:00AM
08:55AM
Apr-14-25 10:00AM
Apr-11-25 11:40AM
Apr-10-25 09:13AM
06:15AM
05:08AM
Apr-07-25 06:15PM
Apr-05-25 06:58AM
Apr-04-25 09:14AM
08:14AM
Apr-02-25 08:00AM
06:00AM
Mar-28-25 03:59PM
Mar-27-25 07:05PM
06:37PM
Mar-24-25 06:15PM
12:33PM
11:40AM
Mar-21-25 05:03AM
Mar-18-25 04:05PM
Mar-03-25 04:04AM
Feb-17-25 08:55AM
Feb-14-25 08:00AM
Feb-12-25 09:12AM
02:08AM
12:06AM
(Thomson Reuters StreetEvents)
Feb-11-25 11:54AM
Feb-10-25 04:39PM
(Associated Press Finance)
04:33PM
04:15PM
Feb-09-25 08:03AM
Feb-07-25 08:14AM
Jan-20-25 08:55AM
Jan-03-25 08:27AM
Jan-02-25 04:05PM
Nov-21-24 06:52PM
Nov-15-24 06:47PM
(Morningstar Research) -7.23%
Nov-06-24 06:36PM
(Morningstar Research) +9.15%
Nov-04-24 10:12AM
Nov-01-24 07:33PM
Oct-29-24 09:00PM
Oct-23-24 03:56AM
(Thomson Reuters StreetEvents)
Oct-22-24 05:42PM
(Morningstar Research) -7.47%
04:04PM
(Investor's Business Daily)
10:09AM
Oct-21-24 04:25PM
(Associated Press Finance)
04:15PM
Oct-16-24 11:23AM
10:44AM
Oct-10-24 01:56PM
07:42AM
Oct-08-24 09:00PM
Sep-30-24 09:00PM
Sep-24-24 05:26PM
04:05PM
Aug-30-24 09:00PM
Aug-29-24 12:40PM
Aug-26-24 04:02PM
Aug-19-24 09:00PM
Aug-16-24 06:45AM
Aug-15-24 02:48PM
Aug-12-24 10:11AM
Aug-05-24 04:08PM
Aug-02-24 07:46PM
Jul-25-24 10:04AM
Jul-24-24 01:01AM
12:55AM
(Thomson Reuters StreetEvents)
Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries. The firm's services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. It operates through the following geographical segments: United States, Europe, Belgium, Asia-Pacific, and Other. The company was founded by August James Troendle in 1992 and is headquartered in Cincinnati, OH.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
DAVENPORT FRED B JR Director Apr 24 '25 Option Exercise 57.17 4,710 269,271 4,710 Apr 28 04:39 PM DAVENPORT FRED B JR Director Apr 24 '25 Sale 301.82 1,712 516,716 2,998 Apr 28 04:39 PM DAVENPORT FRED B JR Director Apr 24 '25 Proposed Sale 301.82 1,712 516,716 Apr 24 02:13 PM Troendle August J. CEO Mar 07 '25 Option Exercise 68.62 356,446 24,458,835 1,011,102 Mar 10 05:47 PM EWALD STEPHEN P General Counsel & Corp. Secy. Feb 27 '25 Buy 326.11 2 652 13,343 Feb 28 04:39 PM Carley Brian T Director Feb 24 '25 Option Exercise 42.62 8,127 346,373 30,035 Feb 26 04:18 PM Carley Brian T Director Feb 24 '25 Sale 345.59 4,003 1,383,397 26,032 Feb 26 04:18 PM Carley Brian T Director Feb 24 '25 Proposed Sale 345.59 4,003 1,383,385 Feb 24 12:52 PM GEIGER JESSE J President Dec 06 '24 Option Exercise 32.05 15,000 480,750 36,503 Dec 10 04:24 PM BURWIG SUSAN E Exec. VP, Operations Nov 19 '24 Option Exercise 32.05 7,500 240,375 65,000 Nov 21 04:40 PM Kraft Robert O. Director Aug 22 '24 Option Exercise 42.62 4,353 185,525 4,873 Aug 26 04:37 PM Kraft Robert O. Director Aug 23 '24 Option Exercise 42.62 3,774 160,848 4,294 Aug 26 04:37 PM Kraft Robert O. Director Aug 22 '24 Sale 390.73 4,353 1,700,848 520 Aug 26 04:37 PM Kraft Robert O. Director Aug 23 '24 Sale 390.73 3,774 1,474,615 520 Aug 26 04:37 PM Kraft Robert O. Director Aug 22 '24 Proposed Sale 390.73 4,353 1,700,858 Aug 22 04:20 PM Keating Ashley M. Former Director Aug 16 '24 Proposed Sale 387.00 769 297,603 Aug 16 04:58 PM Keating Ashley M. Former Director Aug 15 '24 Proposed Sale 388.00 958 371,704 Aug 15 06:27 PM Keating Ashley M. Former Director Aug 09 '24 Proposed Sale 388.29 1,403 544,767 Aug 09 03:50 PM BURWIG SUSAN E Exec. VP, Operations Aug 05 '24 Option Exercise 90.65 50,000 4,532,500 57,500 Aug 07 04:22 PM Keating Ashley M. Former Director Aug 06 '24 Proposed Sale 382.50 2,000 765,000 Aug 06 05:27 PM Keating Ashley M. Former Director Jul 30 '24 Proposed Sale 389.69 1,300 506,600 Jul 30 01:23 PM
